Cheltsov A V, Barber M J, Ferreira G C
Department of Biochemistry and Molecular Biology, College of Medicine, Institute for Biomolecular Science, and H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA.
J Biol Chem. 2001 Jun 1;276(22):19141-9. doi: 10.1074/jbc.M100329200. Epub 2001 Mar 15.
5-Aminolevulinate synthase is the first enzyme of the heme biosynthetic pathway in non-plant eukaryotes and some prokaryotes. The enzyme functions as a homodimer and requires pyridoxal 5'-phosphate as a cofactor. Although the roles of defined amino acids in the active site and catalytic mechanism have been recently explored using site-directed mutagenesis, much less is known about the role of the 5-aminolevulinate synthase polypeptide chain arrangement in folding, structure, and ultimately, function. To assess the importance of the continuity of the polypeptide chain, circularly permuted 5-aminolevulinate synthase variants were constructed through either rational design or screening of an engineered random library. One percent of the random library clones were active, and a total of 21 active variants had sequences different from that of the wild type 5-aminolevulinate synthase. Out of these 21 variants, 9 displayed unique circular permutations of the 5-aminolevulinate synthase polypeptide chain. The new termini of the active variants disrupted secondary structure elements and loop regions and fell in 100 amino acid regions from each terminus. This indicates that the natural continuity of the 5-aminolevulinate synthase polypeptide chain and the sequential arrangement of the secondary structure elements are not requirements for proper folding, binding of the cofactor, or assembly of the two subunits. Furthermore, the order of two identified functional elements (i.e. the catalytic and the glycine-binding domains) is apparently irrelevant for proper functioning of the enzyme. Although the wild type 5-aminolevulinate synthase and the circularly permuted variants appear to have similar, predicted overall tertiary structures, they exhibit differences in the arrangement of the secondary structure elements and in the cofactor-binding site environment. Taken together, the data lead us to propose that the 5-aminolevulinate synthase overall structure can be reached through multiple or alternative folding pathways.
5-氨基乙酰丙酸合酶是非植物真核生物和一些原核生物血红素生物合成途径中的首个酶。该酶以同型二聚体形式发挥作用,需要磷酸吡哆醛作为辅因子。尽管最近利用定点诱变探索了活性位点中特定氨基酸的作用及催化机制,但对于5-氨基乙酰丙酸合酶多肽链排列在折叠、结构以及最终功能方面的作用却知之甚少。为评估多肽链连续性的重要性,通过合理设计或筛选工程化随机文库构建了环状排列的5-氨基乙酰丙酸合酶变体。随机文库克隆中有1%具有活性,总共21个活性变体的序列与野生型5-氨基乙酰丙酸合酶不同。在这21个变体中,9个展示了5-氨基乙酰丙酸合酶多肽链独特的环状排列。活性变体的新末端破坏了二级结构元件和环区,且位于距每个末端100个氨基酸的区域内。这表明5-氨基乙酰丙酸合酶多肽链的天然连续性以及二级结构元件的顺序排列并非正确折叠、辅因子结合或两个亚基组装的必要条件。此外,两个已确定的功能元件(即催化结构域和甘氨酸结合结构域)的顺序对于该酶的正常功能显然无关紧要。尽管野生型5-氨基乙酰丙酸合酶和环状排列的变体似乎具有相似的预测整体三级结构,但它们在二级结构元件的排列以及辅因子结合位点环境方面存在差异。综合来看,这些数据使我们提出5-氨基乙酰丙酸合酶的整体结构可通过多种或替代的折叠途径达成。